+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Determination of the seroprevalence of human immunodeficiency virus infection in gravidas by non-anonymous versus anonymous testing



Determination of the seroprevalence of human immunodeficiency virus infection in gravidas by non-anonymous versus anonymous testing



Obstetrics and Gynecology 74(4): 558-561



From February 16, 1988 to July 15, 1988, a prospective study was undertaken at the University of Illinois Hospital in Chicago to do the following: 1) determine the seroprevalence of human immunodeficiency virus (HIV) infection among our gravid patients, 2) test the hypothesis that methodical counseling would elicit a more thorough recounting of risk factors, and 3) test the hypothesis that those patients who self-identify risk factors represent only a fraction of HIV-positive gravidas. After educational counseling regarding HIV infection, 349 clinic patients (34%) requested non-anonymous HIV testing (group I). Risk factor histories were recorded from these women. Simultaneously, 849 women admitted to labor and delivery were queried with regard to the same risk factors but without preliminary counseling, and then tested anonymously (group II). Nineteen percent (63 of 349) of group I reported risk factors, whereas only 9.6% (82 of 849) of group II reported similar risks (P less than .0001). Two HIV-positive patients were identified in group I, both of whom reported risk factors (seroprevalence 0.6%). Nine HIV-positive patients were detected in group II, but only four reported risk factors (seroprevalence 1.1%). We conclude that methodical counseling may elicit increased reporting of HIV risk factors as compared with questioning without preliminary counseling. Because many HIV-positive patients may be unable or unwilling to report risk factors, selective voluntary testing will not identify all HIV-positive gravidas.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 039787334

Download citation: RISBibTeXText

PMID: 2797632


Related references

Trial of anonymous versus confidential human immunodeficiency virus testing. Lancet 2(8607): 379-382, 1988

Confidential versus anonymous human immunodeficiency virus antibody testing. Western Journal of Medicine 152(1): 75, 1990

Characteristics of clients attending confidential versus anonymous testing clinics for human immunodeficiency virus. Israel Medical Association Journal 3(3): 184-187, 2001

Anonymous human immunodeficiency virus surveillance and clinically directed testing in a Newark, NJ, hospital. Archives of Internal Medicine 151(5): 965-968, 1991

Guidelines on ethical and legal considerations in anonymous unlinked HIV seroprevalence research. Federal Centre for AIDS Working Group on anonymous unlinked HIV seroprevalence. Cmaj 143(7): 625-627, 1990

Human immunodeficiency virus prevalence in women at delivery using unlinked anonymous testing of newborns in the Malaysian setting. Journal of Paediatrics & Child Health 35(1): 63-66, 1999

Anonymous and free-of-charge detection of human immunodeficiency virus infection. 20-months' experience at a center. Presse Medicale 20(4): 163-166, 1991

Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola. South African Medical Journal 103(3): 186-188, 2013

Revised guidelines on ethical and legal considerations in anonymous unlinked HIV seroprevalence research. Federal Centre for AIDS Working Group on Anonymous Unlinked HIV Seroprevalence Research. Cmaj 146(10): 1743-1746, 1992

Clinical assessment of the risk of human immunodeficiency virus infection in the population consulting an anonymous and free screening center. Annales de Dermatologie et de Venereologie 131(1 Cahier 1): 11-15, 2004

Clinical assessment of the risk of Human Immunodeficiency virus (HIV) infection in the population consulting an anonymous and free screening center. Annales de Dermatologie et de Venereologie 131(1 Pt 1): 11-15, 2004

Pilot unlinked anonymous study of human immunodeficiency virus hiv infection amongst genito urinary medicine gum clinic at tenders. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : c347, 1992

Motivations of requests for human immunodeficiency virus (HIV) infection screening at the Centers of Information and Anonymous and Free-of-Charge Screening. Study of 891 cases. Annales de Medecine Interne 150(8): 591-593, 1999

Anonymous survey of the population for the presence of antibodies to human immunodeficiency virus. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii (3): 53-57, 1989

Estimation of human immunodeficiency virus (HIV) seroincidence among repeat anonymous testers in San Francisco. American Journal of Epidemiology 146(8): 662-664, 1997